Latest Medtech News
MedTech funding is moving closer to the hospital floor. This week’s deals back technologies tackling clinical and operational problems - from AI-powered ICU and hospital systems to wound care, infection prevention, brain injury therapy and visual neuroprosthetics.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Tandem Health raises $100M Series B to expand AI-powered clinic software
Tandem Health has raised $100M in Series B funding, led by the Scaleup Europe Fund managed by EQT, bringing its total funding to $160M. The funding will support expansion across Europe and development of its AI-native Clinic Operating System, adding triage, scheduling and patient communications to its existing AI medical assistant.
Co-Founders Oliver Åstrand, Lukas Saari, and Oscar Boldt-Christmas
ReEmerge exits stealth with $37M Series A to advance brain injury therapy
ReEmerge has launched from stealth with an oversubscribed $37M Series A, co-led by U.S. Venture Partners and Santé. The funding will support a clinical study of its Cognitive Network Restoration Therapy (CNRT) for chronic cognitive impairment following traumatic brain injury, alongside technology development and regulatory work.
CEO Todd Langevin: "The strong support of our stellar investor syndicate validates our mission to evolve the recovery trajectory for patients living with impaired cognitive function,"
Piomic Medical secures $25M growth financing to advance wound care system
Swiss medtech company Piomic Medical has secured $25M in growth financing, led by Swisscanto, to advance its COMS One Therapy System for non-healing wounds. The funding will support completion of clinical trials, the U.S. FDA filing and market entry, and expansion of the COMS platform into additional applications.
Founder, Managing Director & Board Member Christopher Hertz
FIZE Medical raises $20M Series B to advance AI-guided ICU care
Israeli medtech company FIZE Medical has raised $20M in Series B funding, co-led by Asahi Kasei Medical and Rapha Capital. The funding will support development of FIZE Optima, an AI-powered platform designed to predict fluid-related risks in critically ill patients, while expanding commercial activities across Europe, Japan and the U.S.
CEO Dror Zerem
MMI secures €17M investment to advance microsurgery robotics
MMI has secured €17M in co-investment from the EIB and Angelini Ventures to advance its robotic microsurgery platform, including the Symani Surgical System. The investment is the third completed under the partners’ €150M healthcare initiative, which has now invested or committed €68.5M across five European life sciences companies.
CEO Mark Toland
Health Force raises €4.2M Seed to expand AI agents for hospital operations
Barcelona-based Health Force has raised €4.2M in Seed funding, led by LUMO Labs, to expand its AI agent platform for automating hospital administrative workflows. The funding will support new applications across quality reporting, clinical trials and resource optimisation, alongside expansion into Germany, France and Spain.
Co-Founder and CEO Fadi Haddad: "Hospitals don’t need another dashboard, they need the work done. We offer hospitals pre-trained AI agents that log into existing systems and complete real work."
Aseptuva advances Far-UVC technology towards clinical development
Swiss-UK medtech company Aseptuva has progressed to preclinical validation following its CHF 2.4M seed round. The company is developing a targeted Far-UVC disinfection technology designed to reduce catheter-related bloodstream infections, and is now opening a CHF 5M Series A to support clinical development and expansion into the UK and U.S.
CEO and Co-FounderHenry Twerenbold: “With hospitals as our primary customers, our goal is to prevent thousands of avoidable deaths, shorten hospital stays, ease the burden on nursing staff, and save healthcare systems millions in preventable costs,”
Phosphoenix secures €1.3M to advance visual neuroprosthetic
Phosphoenix has secured €1.3M in financing from existing investors and new backer ROM InWest. The funding will support preparations for a first-in-human study and further development of its Fountain Probe, a high-density neuroprosthetic designed to stimulate the brain’s visual pathway for people with profound blindness.
CEO Hans Brons: “This financing represents an important step towards bringing our technology into the clinic. Our ultimate goal is to restore meaningful functional vision to people living with profound blindness.”
UCANACT raises €800K to advance brain-computer communication
Utrecht-based neurotech startup UCANACT has raised €800K in pre-seed funding, led by LUMO Labs and Utrecht Holdings Seed Fund, to develop its brain-computer interface (BCI) for people with severe motor impairments. The funding will support development of technology that translates brain signals into computer actions and speech, with three clinical studies already underway.
CEO Julia Berezutskaya
Instalimb secures Series C investment to expand 3D-printed prosthetics
Tokyo-based Instalimb has secured Series C investment from Nippon Express Holdings alongside a capital and business alliance. The partnership will support the global expansion of its AI-designed, 3D-printed prosthetics, with NX Group helping build the supply chain for Instalimb’s printers and materials across emerging markets.
CEO Yutaka Tokushima
